Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy
Clinical trial NCT01728077 · COMPLETED
Trial details
- NCT number
- NCT01728077
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-08-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.